Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
EMS
Behind the Lines
When Talking About Prices Becomes an Antitrust Problem
August 31, 2026
Insights
Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen
May 26, 2026
Insights
EMS to Buy Medley for $600 Million, Deal Set to Face Cade Scrutiny
March 6, 2026
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
